(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ALPHATAC

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ALPHATAC

ST13

US500000097701222

Class

5, 42

Filing

97701222

Registration

8026854

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

04/03/2026

Trademark type

Word

Nice classes

5, 42

Filing date

12/02/2022

Registration date

11/18/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

11/18/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Gent, BE

Examiner

CORWIN, KEVIN SCOTT

Law office

M30

Current location

INTENT TO USE SECTION

Holders and representatives

Holders

V. V. (pessoa física)

Representatives

Clifford D. Hyra FRESH IP PLC

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations and substancesbiotherapeutics for targeted protein degradation in cancerimmunological diseaseautoimmunological disease; Medical preparations and substancesliquidsolidlyophilized protein-based preparations for medical uses and treatments for cancerimmunological diseaseautoimmunological disease; Medical and veterinary preparations and substances in the nature of liquidsolidlyophilized protein-based biotherapeutic preparations for the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; Veterinary preparations in the nature of medication for use in the treatmentmitigationdiagnosisprevention of diseasesconditionssymptoms related to metabolismallergiesimmune and inflammatory diseasesinfectious diseasesthe cardiovascular systemthe pulmonary systemthe respiratory systemoncologydermatologythe gastrointestinal systemtopical illnessesneurologyendocrinologythe urological systemthe reproductive systemnutritional needsophthalmic systemrenal systemblood and blood-related disordersintegumentary and lymphatic systems in humans and animals; therapeutic preparations for pharmaceuticalmedical and veterinary purposespharmaceutical preparations for the treatment of diseasecancerimmunological disordersautoimmunological disorders in humans and animals; bioculture preparations for pharmaceuticalmedicalveterinary purposescultures of microorganisms for medical or veterinary use; Preparations and substances for use in drug discoveryclinical medical reagents; all of the aforesaid goods excluding means for pest controlfungicidesgermicides and herbicides and excluding means for diagnostics

Class 42

Science and technology servicesscientific and technological research in the field of pharmaceuticalsmedical scienceveterinary science; Natural science servicesscientific research; Scientific researchmedicalbacteriologicalchemicalbio-technical and pharmacological research services; Clinical researchscientific research in the nature of conducting clinical trials for others; medical laboratory services; conducting early evaluations in the field of new pharmaceuticals; Consultancy relating to pharmaceutical research and development; Drug discovery services; all of the aforesaid services not relating to means for pest controlfungicidesgermicides and herbicidenot relating to means for diagnostics

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

11/18/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

11/18/2025

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

10/29/2025

IUCN

NOTICE OF ALLOWANCE CANCELLED

10/29/2025

CORV

REVIEW OF CORRESPONDENCE COMPLETE

10/29/2025

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

09/24/2025

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

05/22/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/06/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/11/2025

PUBO

PUBLISHED FOR OPPOSITION

03/11/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/05/2025

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

12/19/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/13/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

08/30/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

08/30/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/30/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/30/2024

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

08/30/2024

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

05/31/2024

GNFR

FINAL REFUSAL E-MAILED

05/31/2024

CNFR

FINAL REFUSAL WRITTEN

05/31/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/21/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/21/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/21/2023

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/23/2023

GNRT

NON-FINAL ACTION E-MAILED

09/23/2023

CNRT

NON-FINAL ACTION WRITTEN

09/23/2023

DOCK

ASSIGNED TO EXAMINER

09/12/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/28/2022

NWAP

NEW APPLICATION ENTERED

12/06/2022

Continuous trademark protection

Get notified about every new filing that threatens ALPHATAC or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.